ArticleDiscover oncology2025
Analysing DNA methylation and transcriptomic signatures to predict prostate cancer recurrence risk.
Fahad M Aldakheel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it